INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)

Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) explained in plain language.

Never miss a new study

Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear

Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 4 Completed 5 Terminated 1

New combo therapy aims to boost success of bile duct cancer surgery

Disease control Terminated

This study tested a treatment given before surgery for bile duct cancer that has a high risk of coming back. The goal was to see if a combination of targeted liver chemotherapy, an immunotherapy drug (atezolizumab), and a blood vessel blocker (bevacizumab) could shrink tumors and…

Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)

Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)

Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear

New combo therapy aims to boost success of bile duct cancer surgery